These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30082741)

  • 1. Novel Nanosized Chitosan-Betulinic Acid Against Resistant Leishmania Major and First Clinical Observation of such parasite in Kidney.
    Zadeh Mehrizi T; Shafiee Ardestani M; Haji Molla Hoseini M; Khamesipour A; Mosaffa N; Ramezani A
    Sci Rep; 2018 Aug; 8(1):11759. PubMed ID: 30082741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis between four model nanoformulations of amphotericin B-chitosan, amphotericin B-dendrimer, betulinic acid-chitosan and betulinic acid-dendrimer for treatment of
    Zadeh Mehrizi T; Khamesipour A; Shafiee Ardestani M; Ebrahimi Shahmabadi H; Haji Molla Hoseini M; Mosaffa N; Ramezani A
    Int J Nanomedicine; 2019; 14():7593-7607. PubMed ID: 31802863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel nano-sized chitosan amphotericin B formulation with considerable improvement against Leishmania major.
    Mehrizi TZ; Ardestani MS; Molla Hoseini MH; Khamesipour A; Mosaffa N; Ramezani A
    Nanomedicine (Lond); 2018 Dec; 13(24):3129-3147. PubMed ID: 30463469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of β-lapachone loaded in lecithin-chitosan nanoparticles for the topical treatment of cutaneous leishmaniasis in L. major infected BALB/c mice.
    Moreno E; Schwartz J; Larrea E; Conde I; Font M; Sanmartín C; Irache JM; Espuelas S
    Nanomedicine; 2015 Nov; 11(8):2003-12. PubMed ID: 26282379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy.
    Saneja A; Kumar R; Singh A; Dhar Dubey R; Mintoo MJ; Singh G; Mondhe DM; Panda AK; Gupta PN
    Int J Pharm; 2017 Oct; 531(1):153-166. PubMed ID: 28823888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactoferrin-modified Betulinic Acid-loaded PLGA nanoparticles are strong anti-leishmanials.
    Halder A; Shukla D; Das S; Roy P; Mukherjee A; Saha B
    Cytokine; 2018 Oct; 110():412-415. PubMed ID: 29784509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(lactic-
    Kumar P; Singh AK; Raj V; Rai A; Keshari AK; Kumar D; Maity B; Prakash A; Maiti S; Saha S
    Int J Nanomedicine; 2018; 13():975-990. PubMed ID: 29497292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiparasitic evaluation of betulinic acid derivatives reveals effective and selective anti-Trypanosoma cruzi inhibitors.
    Meira CS; Barbosa-Filho JM; Lanfredi-Rangel A; Guimarães ET; Moreira DR; Soares MB
    Exp Parasitol; 2016 Jul; 166():108-15. PubMed ID: 27080160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential application of nanochitosan film as a therapeutic agent against cutaneous leishmaniasis caused by L. major.
    Bahrami S; Esmaeilzadeh S; Zarei M; Ahmadi F
    Parasitol Res; 2015 Dec; 114(12):4617-24. PubMed ID: 26346452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan Contribution to Therapeutic and Vaccinal Approaches for the Control of Leishmaniasis.
    Loiseau PM; Pomel S; Croft SL
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32916994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical characterization by AFM, FT-IR and DSC and biological assays of a promising antileishmania delivery system loaded with a natural Brazilian product.
    Marquele-Oliveira F; Torres EC; Barud Hda S; Zoccal KF; Faccioli LH; Hori JI; Berretta AA
    J Pharm Biomed Anal; 2016 May; 123():195-204. PubMed ID: 26897464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral delivery of ursolic acid-loaded nanostructured lipid carrier coated with chitosan oligosaccharides: Development, characterization, in vitro and in vivo assessment for the therapy of leishmaniasis.
    Das S; Ghosh S; De AK; Bera T
    Int J Biol Macromol; 2017 Sep; 102():996-1008. PubMed ID: 28465178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and Cytotoxicity of Polyprenol Lipid and Vitamin E-TPGS Hybrid Nanoparticles for Betulinic Acid and Low-Substituted Hydroxyl Fullerenol in MHCC97H and L02 Cells.
    Tao R; Wang C; Lu Y; Zhang C; Zhou H; Chen H; Li W
    Int J Nanomedicine; 2020; 15():2733-2749. PubMed ID: 32368052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-assembled betulinic acid protects doxorubicin induced apoptosis followed by reduction of ROS-TNF-α-caspase-3 activity.
    Dash SK; Chattopadhyay S; Ghosh T; Dash SS; Tripathy S; Das B; Bag BG; Das D; Roy S
    Biomed Pharmacother; 2015 May; 72():144-57. PubMed ID: 26054689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanovaccine for leishmaniasis: preparation of chitosan nanoparticles containing Leishmania superoxide dismutase and evaluation of its immunogenicity in BALB/c mice.
    Danesh-Bahreini MA; Shokri J; Samiei A; Kamali-Sarvestani E; Barzegar-Jalali M; Mohammadi-Samani S
    Int J Nanomedicine; 2011; 6():835-42. PubMed ID: 21589651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biocompatible polymers coated on carboxylated nanotubes functionalized with betulinic acid for effective drug delivery.
    Tan JM; Karthivashan G; Abd Gani S; Fakurazi S; Hussein MZ
    J Mater Sci Mater Med; 2016 Feb; 27(2):26. PubMed ID: 26704543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic and Antileishmanial Components from the Bark Extract of Ruyschiaphylladenia from Monteverde, Costa Rica.
    Steinberg KM; Shrestha S; Dosoky NS; Monzote L; Piñón A; Haber WA; Setzer WN
    Nat Prod Commun; 2017 Jan; 12(1):1-2. PubMed ID: 30549810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of different parameters under ultrasound irradiation for synthesis of new nanostructured Fe
    Abazari R; Mahjoub AR; Molaie S; Ghaffarifar F; Ghasemi E; Slawin AMZ; Carpenter-Warren CL
    Ultrason Sonochem; 2018 May; 43():248-261. PubMed ID: 29555282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system.
    Ribeiro TG; Chávez-Fumagalli MA; Valadares DG; França JR; Rodrigues LB; Duarte MC; Lage PS; Andrade PH; Lage DP; Arruda LV; Abánades DR; Costa LE; Martins VT; Tavares CA; Castilho RO; Coelho EA; Faraco AA
    Int J Nanomedicine; 2014; 9():877-90. PubMed ID: 24627630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of Betulinic Acid Galactosylated Chitosan Nanoparticles and Their Effect on Liver Fibrosis.
    Wu ZC; Liu XY; Liu JY; Piao JS; Piao MG
    Int J Nanomedicine; 2022; 17():4195-4210. PubMed ID: 36134203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.